Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 17.92B | 16.82B | 13.06B | 12.45B | 9.96B | 4.38B |
Gross Profit | 7.88B | 7.21B | 5.83B | 5.19B | 3.90B | 1.35B |
EBITDA | 1.42B | 1.20B | 908.47M | -1.02B | -1.30B | -1.18B |
Net Income | 875.34M | 444.32M | 150.73M | -1.67B | -2.05B | -1.62B |
Balance Sheet | ||||||
Total Assets | 23.84B | 22.63B | 18.88B | 17.00B | 18.76B | 10.46B |
Cash, Cash Equivalents and Short-Term Investments | 8.43B | 8.62B | 5.36B | 6.89B | 10.16B | 6.29B |
Total Debt | 4.15B | 4.12B | 4.46B | 4.49B | 4.25B | 2.09B |
Total Liabilities | 14.77B | 14.15B | 12.19B | 11.19B | 11.33B | 7.04B |
Stockholders Equity | 8.96B | 8.37B | 6.59B | 5.72B | 7.40B | 3.38B |
Cash Flow | ||||||
Free Cash Flow | 3.50B | 2.96B | 1.82B | -2.03B | -598.53M | 219.59M |
Operating Cash Flow | 3.56B | 3.28B | 2.08B | -1.06B | 208.65M | 555.87M |
Investing Cash Flow | -5.30B | -5.04B | -5.80B | -2.43B | -3.77B | -886.91M |
Financing Cash Flow | 1.78B | 1.68B | 366.01M | 400.26M | 7.40B | 3.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $51.17B | 7.98 | 19.81% | 3.00% | 8.13% | 91.39% | |
77 Outperform | $34.99B | 18.14 | 36.48% | 1.54% | 2.04% | -15.61% | |
74 Outperform | $89.46B | 104.86 | 11.13% | ― | 30.18% | 1995.22% | |
74 Outperform | $126.80B | 60.92 | 49.11% | ― | 41.92% | 81.11% | |
74 Outperform | $54.47B | 216.85 | 6.06% | ― | 20.88% | -80.08% | |
64 Neutral | $5.60B | 37.98 | -39.97% | ― | 2.18% | -32.87% | |
56 Neutral | HK$24.58B | 3.79 | -2.03% | 6.58% | -0.32% | -67.68% |